Biopharma Continues to Buoy the IPO Market

It’s been a rough year for IPOs. So far, just 110 companies have gone public, a 29.9 percent decline from the same period last year, according to Renaissance Capital. One of the…

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.institutionalinvestor.com)